HARROW, INC. — Director's Dealing 2020

Jan 7, 2020

SEC Form 4/A — Form 4/A

Issuer: HARROW HEALTH, INC. (HROW)
CIK: 0001360214
Period of Report: 2020-01-02

Reporting Person: BAUM MARK L (Director, Chief Executive Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-01-02	Option - Right to Buy	$7.30	A	217500	Acquired	2030-01-02	Common Stock (217500)	Direct
2020-01-02	Restricted Stock Unit	$0	A	88000	Acquired	2023-01-02	Common Stock (88000)	Direct

Footnotes

F1: Represents stock options granted under the Issuer's 2017 Stock Incentive and Awards Plan (the "Plan"). The stock options vest in equal quarterly installments over a three-year period.

F2: Represents restricted stock units ("RSUs") granted under the Plan. Each RSU represents a contingent right to receive one share of common stock of the Issuer upon the vesting and settlement of the RSU. The RSUs vest and settle in full on the third anniversary of the date of grant.